Pharma Market Access Insights - from Petauri Evidence
Episodes
Designing a Global Market Access Strategy Built for MFN
21 Apr 2026
Contributed by Lukas
Send us Fan MailHow will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicai...
LATAM Market Access Unlocked: Insights from Argentina, Brazil, Colombia, and Mexico
02 Apr 2026
Contributed by Lukas
Send us Fan MailHow do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global m...
The Evolving NHS – An ICS Chief Pharmacist’s Perspective
17 Nov 2025
Contributed by Lukas
Send a textWhat does the evolving NHS landscape look like through the eyes of a Chief Pharmacist, and how are integrated care system (ICS) pharmacy te...
First to Market: Unlocking Switzerland’s Pharma Potential
12 Nov 2025
Contributed by Lukas
Send a textWhat makes Switzerland a compelling first-launch market for Pharma? How does its healthcare system compare to other European countries? Wha...
Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice
13 Oct 2025
Contributed by Lukas
Send a textIn this NHS Whispers live Q&A webinar, Katie Mulholland (Senior Consultant, UK Market Access, Petauri Evidence) speaks to: - Sarah Eve...
Global Pricing and Market Access – Strategies for Success in an Evolving Landscape
18 Jul 2025
Contributed by Lukas
Send a textUncover the forces driving change in global pricing and accessIn this expert-led discussion we explore the latest trends, challenges, and s...
Transforming Global Market Access: Smarter Resource Management with Local Affiliates
03 Jun 2025
Contributed by Lukas
Send a textDiscover a smarter way to manage and share market access resources with local affiliatesAre your global market access resources scattered, ...
Communicating value to US Payers: Insights for Pharma and Medtech
29 Apr 2025
Contributed by Lukas
Send a textWhat do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? Wh...
Navigating market access: Launch strategies and health economic modelling for medical devices
24 Apr 2025
Contributed by Lukas
Send a textDiscover how health economics can support successful Medical Device launch, proposition development, and market accessThis episode offers a...
Navigating US payer evidence needs to optimise market access
27 Nov 2024
Contributed by Lukas
Send a textWhat clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential acc...
Best practice RWE approaches to support economic modelling for HTA
20 Nov 2024
Contributed by Lukas
Send a textHow can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can R...
NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas
18 Nov 2024
Contributed by Lukas
Send a textHow is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and suppo...
De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
11 Oct 2024
Contributed by Lukas
Send a textAre you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level wi...
NHS primary care panel – the GP Contract and Operational Planning Guidance
10 Sep 2024
Contributed by Lukas
Send a textWhat can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contra...
Engage NHS healthcare decision-makers with RWD
12 Aug 2024
Contributed by Lukas
Send a textDiscover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real...
Market access and reimbursement in Canada – changes at CADTH
20 Jun 2024
Contributed by Lukas
Send a textWhat do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency f...
Rare Disease market access in the MENA and Nordic regions
10 May 2024
Contributed by Lukas
Send a textWhere will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in k...
How does funding flow in NHSE Regions?
09 Apr 2024
Contributed by Lukas
Send a textWhich decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best s...
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)
09 Apr 2024
Contributed by Lukas
Send a textWhat do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and...
De-mystifying health economic model classifications and structures
22 Mar 2024
Contributed by Lukas
Send a textWhat is health economic evaluation and which modelling approaches can be used to support market access activities?In this episode, our expe...
Evidence strategy for Medical Technologies and Diagnostics
12 Mar 2024
Contributed by Lukas
Send a textHere, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies.Have you established the cli...
How to set your Pharma or Medtech product up for success in the US market
26 Feb 2024
Contributed by Lukas
Send a textHow can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Glo...
What's happening with specialised commissioning in the NHS?
12 Feb 2024
Contributed by Lukas
Send a textWhat’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and...
Integrated care in NHS Wales – what can England learn from its neighbour?
17 Jan 2024
Contributed by Lukas
Send a textWhat does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the f...
Market access in Italy: Reforms at AIFA
18 Dec 2023
Contributed by Lukas
Send a textClare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of H...
Unmet need in NHS primary care – How can industry best support PCN leaders?
28 Nov 2023
Contributed by Lukas
Send a textDr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore...
Population health management: a community effort across health and life sciences
01 Nov 2023
Contributed by Lukas
Send a textHow can our community support NHS leaders to deliver a data-led, people-centric health service?Dr Mark Davies (Global Chief Health Officer,...
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
26 Oct 2023
Contributed by Lukas
Send a textHow is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where ca...
6 areas of UK health policy for Medtech to pay attention to
16 Oct 2023
Contributed by Lukas
Send a textHow is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators?Robert Hull (Senior ...
Market access in the German speaking markets
29 Aug 2023
Contributed by Lukas
Send a textHere we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) sp...
The role of nursing in driving digital change in the NHS
26 Jul 2023
Contributed by Lukas
Send a textHow are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinic...
Market access for digital therapies and digital medicines
19 Jul 2023
Contributed by Lukas
Send a textIn this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Acces...
A global market access journey in cannabinoid pharmaceuticals
17 Jun 2023
Contributed by Lukas
Send a textWhat does it take to bring a cannabinoid pharmaceutical to market?We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceutic...
Primary Care and ICBs – what is the next step in the integration journey?
15 May 2023
Contributed by Lukas
Send a textHow will changes to the structure of primary care impact decision making?How is the relationship between Integrated Care Boards (ICBs) and ...
Data-led transformation in the NHS - partnering to optimise patient care
31 Mar 2023
Contributed by Lukas
Send a textIs data the key to transforming healthcare systems and patient care?What are the top priorities for digital transformation leaders in the N...
Innovating for better health – research, collaboration and innovation in the NHS
07 Mar 2023
Contributed by Lukas
Send a textHow and where can innovation drive improvements in care and deliver better health for the population?How is the NHS looking to collaborate ...
Healthcare, economics and society – unlocking NHS collaboration
30 Jan 2023
Contributed by Lukas
Send a textWill NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change?What social and ...
Specialised Commissioning in the NHS – What do you need to know now
13 Jan 2023
Contributed by Lukas
Send a textThe proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for...
Why are we waiting? - Pressures facing the NHS and how to deliver change
29 Nov 2022
Contributed by Lukas
Send a textWith so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systema...
Priority setting in primary care - NHS insights
18 Oct 2022
Contributed by Lukas
Send a textHow is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does syste...
Integrated Care Systems go live in the NHS - reflections after 3 weeks
09 Aug 2022
Contributed by Lukas
Send a textOn 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for ...
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role
01 Aug 2022
Contributed by Lukas
Send a textWhat roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how ca...
Transforming systems and care pathways for an integrated NHS
21 Jun 2022
Contributed by Lukas
Send a textAs the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, a...
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers
04 May 2022
Contributed by Lukas
Send a textOur experts in health economics, value communication, design and digital discuss how to craft digital payer value communication tools to me...
Population to Person: How will the NHS translate population health management into impactful, person-centred service change?
15 Mar 2022
Contributed by Lukas
Send a textWhat does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health manag...
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?
11 Feb 2022
Contributed by Lukas
Send a textWhat does the ‘2022/23 priorities and operational planning guidance’ document mean for the NHS, for Integrated Care System (ICS) develo...
The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion
17 Jan 2022
Contributed by Lukas
Send a textPharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical ...
Optimising the NHS – How will medicines be valued in integrated systems?
21 Dec 2021
Contributed by Lukas
Send a textHow will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What...
Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe
29 Nov 2021
Contributed by Lukas
Send a textWe explore the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe.O...
A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)
01 Oct 2021
Contributed by Lukas
Send a textHow are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-makin...
Innovations to address health inequalities in the NHS and how Pharma and Medtech can help
10 Sep 2021
Contributed by Lukas
Send a textHow can the NHS address health inequalities through innovation? How can new health technologies help improve population health? How can Pha...
The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving
06 Jul 2021
Contributed by Lukas
Send a textWhat role do Ambulance Trusts play in the success of the wider NHS? How might urgent and community care evolve as we head to integration as...
Population to person - How will the voice of the individual drive health and care development?
02 Jun 2021
Contributed by Lukas
Send a textPopulation health management is often talked about in top-down terms, but how seriously will the needs of individuals be taken as systems d...
Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE
17 May 2021
Contributed by Lukas
Send a textWhat will a ‘Place’ look like? What will this new layer of the NHS mean in practice and what decision-making powers will Place leaders ...
Health Economic Modelling for MedTech Innovation - What, Why and How
14 Apr 2021
Contributed by Lukas
Send a textAre you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know...
Pharmacy, Medicines, and Specialised Commissioning in the new NHS
12 Apr 2021
Contributed by Lukas
Send a textWhat changes can we expect to pharmacy, medicines management, and specialised commissioning in the new NHS? Professor Inderjit Singh (Chi...
The White Paper and integrated care in the NHS: What it really means in practice for clinicians, patients and us - with Dr John Ribchester
11 Mar 2021
Contributed by Lukas
Send a textAre you wondering what integrated care will look like when the Health and Care White Paper proposals become a reality? Tom Clarke interview...
Heads at the heart of the NHS: How mental health is central to everything in the new NHS - with Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust)
05 Feb 2021
Contributed by Lukas
Send a textWith mental health services facing unique challenges, Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust),...
Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus
13 Jan 2021
Contributed by Lukas
Send a textWith new policy passing power to Integrated Care Systems (ICS), we explore how pharmacy and medicines commissioning will work in the new sy...
Is prevention better than the cure? How can the NHS and public health work closer to improve population health?
27 Nov 2020
Contributed by Lukas
Send a textDr Peter Brambleby (Independent Public Health Consultant) joins Tom Clarke (Director, Mtech Access) to discuss the role public health has p...
Understanding the tipping point: When elective becomes selective in NHS surgery
16 Nov 2020
Contributed by Lukas
Send a textSimon Parsons (Divisional Director of Surgery at Nottingham University Hospitals NHS Trust) joins Tom Clarke (Director, Mtech Access) to di...
Leading within an evolving, integrating system: insights from an NHS leader
21 Oct 2020
Contributed by Lukas
Send a textDiscover what it’s like to be a leader in today’s NHS and how industry can best support NHS leaders. Deborah Lee (Chief Executive of Gl...
Integrated Care Systems: Separating fact from myth – insights from a system leader
15 Oct 2020
Contributed by Lukas
Send a textDr Claire Fuller (Senior Responsible Officer at Surrey Heartlands Health and Care Partnership) joins Tom Clarke(Director, Mtech Access) to ...
The Evolving NHS - Lessons for Pharma and Medtech - NHS insights webinar with David Thorne and Tom Clarke
09 Oct 2020
Contributed by Lukas
Send a textFrom capacity management to changing performance measures, discover what’s changing in the NHS, the impact on the NHS long-term plan and ...
The Role of the Independent Sector, Post-COVID with Jim Easton (CEO of Care UK)
11 Aug 2020
Contributed by Lukas
Send a textWe are joined by Jim Easton (CEO of Care UK) to discuss the role of the independent sector in supporting the NHS and the wider care industr...
The Tech Perspective with Stephen Bourke (Co-Founder of Echo, The Online Pharmacy)
05 Aug 2020
Contributed by Lukas
Send a textWe explore a different aspect of the COVID response, speaking with Stephen Bourke (Co-Founder of Echo), to learn how Echo and other tech co...
Questions Time Special - Views from across the NHS; from costings to strategy to clinical care
30 Jul 2020
Contributed by Lukas
Send a textIn this 'Questions Time' special we welcome a broad panel of practitioners from across the NHS to explore the themes of care deli...
The Changing Face of Care Delivery Part 2: The Primary Care & Community View with Steve Reed (Head of Community Services, York Teaching Hospitals NHS FT) and Dr John Ribchester (PCN Clinical Director, GP and Chair of Encompass GP Partnership, Whitstable)
20 Jul 2020
Contributed by Lukas
Send a textWith Steve Reed (Head of Community Services, York Teaching Hospitals NHS FT) and Dr John Ribchester (PCN Clinical Director, GP and Chair of...
The Changing Face of Care Delivery Part 1: The System & Hospital View with Berenice Groves (Director of Operations, Blackpool Teaching Hospitals NHS FT) and Tina Teague (COVID Resilience Manager for Devon)
14 Jul 2020
Contributed by Lukas
Send a textIn this, the first of two sessions looking at the changing face of care delivery, Berenice Groves (Director of Operations, Blackpool Teachi...
Strategic Procurement & Medicines Management with Keith Pearson (Head of Medicines Optimisation, in a CCG) and Simon Wootton (Non Exec Director, in a PCN)
22 Jun 2020
Contributed by Lukas
Send a textListen as Keith Pearson (Head of Medicines Optimisation, Heywood, Middleton and Rochdale CCG) and Simon Wootton (Non Exec Director, Rossend...
Pharmacy & Medicines Management with Samantha O’Connell (GP Clinical Pharmacist) and Johnathan Laird (Prescribing Pharmacist)
19 Jun 2020
Contributed by Lukas
Send a textDiscover the opportunities and challenges facing pharmacy and medicines management in the NHS. We speak to Samantha O’Connell (GP Clinica...
Finance & Commissioning with Patrick McGinley (Head of Costings and SLR) and Patricia Whelan-Moss (Head of Organisational Development for a CCG)
18 Jun 2020
Contributed by Lukas
Send a textWe explore the worlds of finance and commissioning in the NHS with insights from Patrick McGinley (Head of Costings and SLR, Maidstone &...
Primary Care & Community Settings with Liz Cross (Advanced Nurse Practitioner) & Dr Su McCole (GP & Area Clinical Director)
09 Jun 2020
Contributed by Lukas
Send a textWe focus in on primary care and community settings with insights from Liz Cross (Advanced Nurse Practitioner) and Dr Su McCole (GP & Ar...
Introductory overview with PCN lead Hilary Snowdon & Secondary Care Chief Exec Mike Proctor
02 Jun 2020
Contributed by Lukas
Send a textIn our COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) asks experts holding operational, strategic ...